A Novel Variant in the Platelet Endothelial Aggregation Receptor-1 Gene Is Associated With Increased Platelet Aggregability

Publisher Website
Google Scholar
Abstract
Objective— Platelet endothelial aggregation receptor-1 (PEAR1) is a recently identified platelet transmembrane protein that becomes activated by platelet contact. We looked for novel genetic variants in PEAR1 and studied their association with agonist-induced native platelet aggregation and with the inhibitory effect of aspirin on platelets. Methods and Results— We genotyped PEAR1 for 10 single nucleotide polymorphisms (SNPs), selected for optimal gene coverage at a density of 4 kb, in 1486 apparently healthy individuals from two generations of families with premature CAD. Subjects had a mean age of 45 years; 62% were white and 38% black. Platelet aggregation to collagen, epinephrine, and ADP was measured in platelet rich plasma, at baseline and after 2 weeks of aspirin (ASA, 81 mg/d), and genotype-phenotype associations were examined separately by ethnicity using multivariable generalized linear models adjusted for covariates. The C allele of SNP rs2768759 [A/C], located in the promoter region of the gen... This study examined the association between genetic variants in platelet endothelial aggregation receptor-1 (PEAR1) and platelet function in 1486 healthy individuals from families with premature CAD. The C allele of SNP rs2768759, in the promoter region, was common in whites and uncommon in blacks but was associated with greater platelet aggregation to collagen, epinephrine, and ADP in native platelets and after aspirin in both ethnic groups. PEAR1 appears to play an important role in platelet function.